아이센스

099190KOSDAQ의료용 기기 제조업

48.5 / 100

Reference Date: 2026-07-24

Financial Score12.0 / 40

News Sentiment18.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is below the industry average, ROE is below the industry average. Slightly up 4.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ai-Sensor is a company that develops, manufactures, and sells medical sensors and diagnostic equipment based on electrochemical and biosensor technologies. Its main business segments include blood glucose meters and point-of-care testing (POCT) devices. The blood glucose meter segment offers products with high accuracy and precision, while the CareSens Air continuous glucose monitoring system stands out with a competitive MARD value of 9%. The POCT segment provides a range of medical equipment, including electrolyte/gas analyzers and coagulation measurement devices.

Number of Employees

957people

Average Salary

55.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 20.044.0Point

PBR

1.35Industry Average 1.142.5Point

Higher than industry avg (caution)

ROE

-1.96Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

21.41Industry Average 11.650.5Point

1.8x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲60.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.5% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 74

Positive
30년 연구 결실…세계 첫 '7일 인슐린 패치펌프' 만든 교수창업가
아이센스의 주요 경쟁사인 케어메디의 혁신적인 7일 인슐린 패치펌프 출시로 인해 관련 시장에서의 경쟁력 강화가 예상됩니다.
Positive
아이센스, 차세대 CGM '케어센스 에어 2' 유럽 CE 인증 신청
아이센스의 차세대 CGM '케어센스 에어 2'가 유럽 CE 인증 신청으로 인해 긍정적인 시장 반응을 기대할 수 있다.
Positive
췌장장애 인정에 CGM 시장 다시 주목…2형당뇨 급여가 변수
췌장장애 인정으로 CGM 시장 재조명, 아이센스의 연속혈당측정기 판매 증가 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 15,910Won52-week high 27,00052-week low 14,690

1-month return4.0Point

1m +4.12% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-21
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30